The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression
Sandii Brimble
1
,
Edith Wollaston-Hayden
1
,
Chin Hai Teo
1
,
Andrew J. Morris
1
,
Lance Wells
2, 3
Publication type: Journal Article
Publication date: 2010-01-01
scimago Q4
SJR: 0.150
CiteScore: 1.9
Impact factor: —
ISSN: 15743624
PubMed ID:
25484640
Pharmacology (medical)
Endocrinology
Abstract
O-linked β-N-acetylglucosamine (O-GlcNAc) modification of proteins has been shown to be involved in many different cellular processes, such as cell cycle control, nutrient sensing, signal transduction, stress response and transcriptional regulation. Cells have developed complex regulatory systems in order to regulate gene expression appropriately in response to environmental and intracellular cues. Control of eukaryotic gene transcription often involves post-translational modification of a multitude of proteins including transcription factors, basal transcription machinery, and chromatin remodeling complexes to modulate their functions in a variety of manners. In this review we describe the emerging functional roles for and techniques to detect and modulate the O-GlcNAc modification and illustrate that the O-GlcNAc modification is intricately involved in at least seven different general mechanisms for the control of gene transcription.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
Frontiers in Endocrinology
2 publications, 6.9%
|
|
|
Journal of Biological Chemistry
2 publications, 6.9%
|
|
|
Marine Drugs
1 publication, 3.45%
|
|
|
Cancers
1 publication, 3.45%
|
|
|
Clinical Proteomics
1 publication, 3.45%
|
|
|
Cell
1 publication, 3.45%
|
|
|
PLoS Genetics
1 publication, 3.45%
|
|
|
Fish and Shellfish Immunology
1 publication, 3.45%
|
|
|
Clinica Chimica Acta
1 publication, 3.45%
|
|
|
Cell Biology International
1 publication, 3.45%
|
|
|
Angewandte Chemie
1 publication, 3.45%
|
|
|
Angewandte Chemie - International Edition
1 publication, 3.45%
|
|
|
FASEB Journal
1 publication, 3.45%
|
|
|
ACS Chemical Biology
1 publication, 3.45%
|
|
|
ACS Central Science
1 publication, 3.45%
|
|
|
Chemical Reviews
1 publication, 3.45%
|
|
|
Glycobiology
1 publication, 3.45%
|
|
|
International Journal of Molecular Sciences
1 publication, 3.45%
|
|
|
eLife
1 publication, 3.45%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
1 publication, 3.45%
|
|
|
Epigenetics and Chromatin
1 publication, 3.45%
|
|
|
Acta Pharmacologica Sinica
1 publication, 3.45%
|
|
|
Carbohydrate Research
1 publication, 3.45%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
|
|
|
Elsevier
5 publications, 17.24%
|
|
|
Cold Spring Harbor Laboratory
4 publications, 13.79%
|
|
|
MDPI
3 publications, 10.34%
|
|
|
Springer Nature
3 publications, 10.34%
|
|
|
Wiley
3 publications, 10.34%
|
|
|
American Chemical Society (ACS)
3 publications, 10.34%
|
|
|
Frontiers Media S.A.
2 publications, 6.9%
|
|
|
Public Library of Science (PLoS)
1 publication, 3.45%
|
|
|
American Society for Biochemistry and Molecular Biology
1 publication, 3.45%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 3.45%
|
|
|
Oxford University Press
1 publication, 3.45%
|
|
|
eLife Sciences Publications
1 publication, 3.45%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 3.45%
|
|
|
1
2
3
4
5
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
29
Total citations:
29
Citations from 2024:
3
(10.35%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Brimble S. et al. The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression // Current Signal Transduction Therapy. 2010. Vol. 5. No. 1. pp. 12-24.
GOST all authors (up to 50)
Copy
Brimble S., Wollaston-Hayden E., Hai Teo C., Morris A. J., Wells L. The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression // Current Signal Transduction Therapy. 2010. Vol. 5. No. 1. pp. 12-24.
Cite this
RIS
Copy
TY - JOUR
DO - 10.2174/157436210790226465
UR - https://doi.org/10.2174/157436210790226465
TI - The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression
T2 - Current Signal Transduction Therapy
AU - Brimble, Sandii
AU - Wollaston-Hayden, Edith
AU - Hai Teo, Chin
AU - Morris, Andrew J.
AU - Wells, Lance
PY - 2010
DA - 2010/01/01
PB - Bentham Science Publishers Ltd.
SP - 12-24
IS - 1
VL - 5
PMID - 25484640
SN - 1574-3624
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2010_Brimble,
author = {Sandii Brimble and Edith Wollaston-Hayden and Chin Hai Teo and Andrew J. Morris and Lance Wells},
title = {The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression},
journal = {Current Signal Transduction Therapy},
year = {2010},
volume = {5},
publisher = {Bentham Science Publishers Ltd.},
month = {jan},
url = {https://doi.org/10.2174/157436210790226465},
number = {1},
pages = {12--24},
doi = {10.2174/157436210790226465}
}
Cite this
MLA
Copy
Brimble, Sandii, et al. “The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression.” Current Signal Transduction Therapy, vol. 5, no. 1, Jan. 2010, pp. 12-24. https://doi.org/10.2174/157436210790226465.